Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis

BACKGROUND: Reports of triple combination therapy for neovascular age-related macular degeneration (AMD) suggest a benefit, as do reports for zeaxanthin. An interventional comparative study was thus undertaken to evaluate the efficacy of triple combination therapy with and without zeaxanthin, as wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Olk, R. Joseph, Peralta, Enrique, Gierhart, Dennis L., Brown, Gary C., Brown, Melissa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088486/
https://www.ncbi.nlm.nih.gov/pubmed/27847615
http://dx.doi.org/10.1186/s40942-015-0019-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088486/
https://www.ncbi.nlm.nih.gov/pubmed/27847615
http://dx.doi.org/10.1186/s40942-015-0019-2

Ejemplares similares